Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care

Published:2016-05-27 Issue:11 Volume:25 Page:1236-1244
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Gorst-Rasmussen Anders¹²,Lip Gregory Y. H.²³,Bjerregaard Larsen Torben²⁴

Affiliation:

1. Unit of Clinical Biostatistics and Bioinformatics; Aalborg University Hospital; Aalborg Denmark

2. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health; Aalborg University; Aalborg Denmark

3. University of Birmingham Centre for Cardiovascular Sciences; City Hospital; Birmingham United Kingdom

4. Department of Cardiology, Atrial Fibrillation Study group; Aalborg University Hospital; Aalborg Denmark

Funder

The Obel Family Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference28 articles.

1. Interpreting the quality of health care database studies on the comparative effectiveness of oral anticoagulants in routine care;Huybrechts;Comp Eff Res,2013

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation;Graham;Circulation,2015

4. Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: a prospective nationwide cohort study;Larsen;J Am Coll Cardiol,2013

5. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry;Beyer-Westendorf;Blood,2014

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients with or Susceptible to Thromboembolic Events;South Medical Journal;2023-09-01

2. A review of the use of propensity score methods with multiple treatment groups in the general internal medicine literature;Pharmacoepidemiology and Drug Safety;2023-05-16

3. Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-01-19

4. Safety and efficacy of apixaban, dabigatran and rivaroxaban in obese and morbidly obese patients with heart failure and atrial fibrillation: A real‐world analysis;Pacing and Clinical Electrophysiology;2022-12

5. Assessing Medicines for Use in the Geriatric Population;Clinical Pharmacology & Therapeutics;2022-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3